Does ATORVASTATIN Cause Hepatic cytolysis? 681 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 681 reports of Hepatic cytolysis have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.9% of all adverse event reports for ATORVASTATIN.
681
Reports of Hepatic cytolysis with ATORVASTATIN
0.9%
of all ATORVASTATIN reports
3
Deaths
388
Hospitalizations
How Dangerous Is Hepatic cytolysis From ATORVASTATIN?
Of the 681 reports, 3 (0.4%) resulted in death, 388 (57.0%) required hospitalization, and 14 (2.1%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 681 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
PEMETREXED (252)
Which ATORVASTATIN Alternatives Have Lower Hepatic cytolysis Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM